Latest Breaking News On - International society of paediatric oncology - Page 1 : comparemela.com

Families join SCCS activity to celebrate Int l Childhood Cancer Day

Families join SCCS activity to celebrate Int l Childhood Cancer Day
theborneopost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theborneopost.com Daily Mail and Mail on Sunday newspapers.

Rodney wongSarawak children cancer societyInternational society of paediatric oncologyInternational childhood cancer dayChildhood cancer internationalSarawak childrenCancer societySarawak general hospitalPaediatric specialist clinicPaediatric wardUnveiling challengesSarawak generalInternational societyPaediatric oncologyUnveiling challengesInspiring action

WOWS part of the campaign to unveil challenges and inequalities surrounding childhood cancer care

WOWS part of the campaign to unveil challenges and inequalities surrounding childhood cancer care
fijivillage.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fijivillage.com Daily Mail and Mail on Sunday newspapers.

Ministry of healthInternational society of paediatric oncologyChildhood cancer internationalInternational childhood cancer dayWalk on strongKids fijiInternational societyPaediatric oncologyAccess to carePaediatric oncology unitsOncology ward

EMA Validates MAA for Repotrectinib in ROS1+ NSCLC and NTRK+ Solid Tumors

The European Medicines Agency has validated its marketing authorization application for repotrectinib in adult patients with ROS1 TKI-naive or -pretreated locally advanced or metastatic non–small cell lung cancer harboring ROS1 fusions, as well as adult and pediatric patients with TKI-naive and pretreated NTRK-positive locally advanced or metastatic solid tumors.

United statesRepotrectinib augtyroJoseph fioreEuropean medicines agencyDrug administrationPoint therapeutics incVirtual congressZai labZai lab partner turning point therapeuticsInternational society of paediatric oncologyBristol myers squibbAfrican americanInternational societyPaediatric oncologyMedicines agencyUpdated november

Asparaginase Hypersensitivity: Immune Reactions of a Key Tool Against ALL

Oncology nurses must be on the look-out for immune hypersensitivity reactions and other serious toxicities in patients receiving L-asparaginase.

United statesUnited kingdomUniversity of southern californiaIbrahim aldossLos angelesDan douerSpencerj andersonDrug administrationInternational society of paediatric oncologyUniversity of british columbiaCity of hope medical centerHope medical centerSouthern californiaInternational societyPaediatric oncologyBritish columbia

Risk-Stratified Pediatric ALL Treatment Improves Outcomes, Reduces Drug Exposure

Modifications to a pediatric ALL treatment protocol improved outcomes in IKZF1del, ETV6::RUNX1, and poor prednisone response ALL; and Down syndrome.

Rob pietersDutch childhood oncology groupInternational society of paediatric oncologyUniversity of utrechtInternational societyPaediatric oncologyPediatric oncologyDown syndromeDown syndrome associated